Data from Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
Shogo Shigeta(Tohoku University), Christopher J. Kemp(Fred Hutch Cancer Center), Reid Shaw(Precision for Medicine (United States)), Kay E. Gurley(Fred Hutch Cancer Center), Goldie Y.L. Lui(Fred Hutch Cancer Center), Carla Grandori(Precision for Medicine (United States)), Rachele Rosati(Precision for Medicine (United States)), Elizabeth M. Swisher(University of Washington), Grace Durenberger(Precision for Medicine (United States)), Russell Moser(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert L. Diaz, Tan A. Ince(NewYork–Presbyterian Brooklyn Methodist Hospital)
Cited by 0
Related Papers
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
|Proceedings of the National Academy of Sciences|2000|827
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
|Nature Cell Biology|2005|671